New Minnetronix CFO started yesterday
The new CFO of Minnetronix, Phil Ankeny, joined the company today. Ankeny moved over to Minnetronix from SurModics Inc., where he served as interim CEO and CFO. His background is in venture capital, IT startups and investment banking.
titanmedical
iPhone ECG maker AliveCor names Judy Wade president & CEO | Personnel Moves
Teleflex gains on acquisitions, Q1 numbers | Wall Street Beat
Shares of Teleflex (NYSE:TFX) are up today after the medical device maker revealed a pair of acquisitions and earnings well above Wall Street’s expectations.
Limerick, Pa.-based Teleflex said it inked deals to buy the EZ-Blocker pulmonary catheter technology and Axiom Technology Partners, which makes the EFx line of laparoscopic fascial closure devices.
Standard & Poor’s gives Medtronic an A+ | Wall Street Beat
Standard & Poor’s Ratings Services affirmed Medtronic’s (NYSE:MDT) long-term debt’s “A+” rating yesterday, after the med-tech titan announced another debt offering.
The rating agency said its view of Medtronic’s senior unsecured notes and its stable rating outlook “reflect the company’s ‘strong’ business risk profile and ‘modest’ financial risk profile.”
Piper Jaffray: Abiomed wins reimbursement code | Wall Street Beat
Abiomed (NSDQ:ABMD) is slated to win a reimbursement code for procedures involving its Impella heart pump, according to analysts at Piper Jaffray.
In a summary of recent editorial panel decisions, the American Medical Assn. revealed that the panel approved the Society for Cardiovascular Angiography and Interventions’ proposal for the reimbursement code, according to theflyonthewall.com.
Is Boston Scientific in line for a private equity takeover? | Wall Street Beat
Billionaire hedge fund manager David Tepper, of Appaloosa Management, bought 7.8 million shares of Boston Scientific stock during the 4th quarter, according to regulatory filings, for a stake with a market value of $41.6 million as of Dec. 31.
Ortho market growth stable but low | Wall Street Beat
The market for hip and knee implants is stable but mired in a low-growth stage, according to analysts who attended the American Academy of Orthopedic Surgeons conference in San Francisco last week.
Although the abrupt departure of Stryker CEO Steve MacMillan drew the lion’s share of attention at the AAOS event, analysts from Barclays Capital and Leerink Swann agreed that the sector’s outlook calls for low-single-digit growth.
J&J CEO Weldon: Medical sales slump has bottomed out | Wall Street Beat
The sales slump endured by the medical industry as the economic crisis hit may be over, according to Johnson & Johnson CEO William Weldon.
That means procedure volumes for elective surgeries could rebound, Weldon told Bloomberg after the company released its financial results for the 4th quarter and 2011.
Surgical snake maker lands $11.7M in Series C | Funding Roundup
Surgical snake technology developer Medrobotics Corp. closed a $11.7 million Series C funding round led by current shareholders, angel investors and the Pittsburgh Life Sciences Greenhouse.
Medrobotics, originally known as Cardiorobotics, has raised $28.3 million since it spun out of Carnegie Mellon University in 2005.
The Boston, Mass.-based med-tech maker’s robots allow surgeons to perform 2-handed surgeries in hard-to-reach anatomical areas. The robots can support their own weight and move in any 3D space without structural support.
Mela Sciences announces $15M public offering | Funding Roundup
Mela Sciences (NSDQ:MELA) priced a public offering of 5 million shares of common stock at $3.25 per share, hoping to raise up to $14.9 million.
President & CEO Joseph Gulfo and director Robert Coradini agreed to purchase 43,000 shares at the Dec. 15 closing price of $3.97 per share.
Diabetes: FDA clears iPhone glucose meter | MassDevice.com On Call
MASSDEVICE ON CALL — Sanofi’s (NYSE:SNY) iPhone glucose meter, the iBGStar, landed 510(k) clearance from the FDA, making it the first iPhone glucose meter to win a nod from the federal watchdog agency.
The company’s website describes the meter as "is the first available blood glucose meter that seamlessly connects to the Apple iPhone and iPod touch for the flexibility to manage your diabetes whenever, wherever."